Sitemap
November 21, 2017 Articles
Filter by Available Specialty
- C. difficile persists most frequently in floor corners after disinfection
- 2 studies underscore high CV risk in primary aldosteronism, despite treatment
- ACIP recommends third MMR dose during mumps outbreaks
- ACP: Improving health care price transparency ‘vital’
- ACR asks CMS to 'remove barriers' between small practices, alternative payment models
- ALLHAT
- Approach to ECG Interpretation
- ARBITER 6-HALTS
- ARISTOTLE Trial
- As Madagascar plague outbreak loosens grip, concerns linger
- ASCEND-HF Trial
- ASCERT Trial
- ATHENA Trial
- ATLAS ACS 2-TIMI 51 Trial
- Atrial Tachycardia - Paroxysmal
- BLOG: November, again!
- BLOG: Some early postop issues just need a tincture of time
- Bone loss remains elevated 5 years after RYGB vs. sleeve gastrectomy
- Causes of immunotherapy-related side effects in cancer require more research
- CDC: Raw milk contaminated with dangerous bacteria sold in four states
- Cholera: A disease with unending epidemics
- Considerations for patients with Ehlers-Danlos syndromes undergoing surgery
- Current guidelines underestimate statin eligibility after MI in young adults
- Decades later, still no vaccine or treatment for West Nile virus
- DECIDE-LVAD: Decision-making tool improves decision quality among LVAD candidates
- Discontinuity of care increases risk for unplanned hospital admissions among elderly patients
- DT MedTech receives 510(k) FDA clearance for total ankle replacement system
- Durable change in antibiotic prescribing requires long-term interventions
- Endoluminal bypass shows promise for PAD
- Ethanol lock therapy does not prevent treatment failure from CLABSIs
- FDA accepts NDA for Aristada dispersion product
- FDA announces policy framework to develop regenerative medicine products
- FDA approves first two-drug HIV regimen, Juluca
- FDA approves herpes zoster vaccine Shingrix
- FDA issues guidance on developing generic abuse-deterrent opioids
- H1N1 may double risk for diabetes
- Hemlibra prophylaxis reduces treated bleeds for certain patients with hemophilia A
- HIV care outcomes improve among MSM
- Hormonal birth control may increase risk for suicide
- HPV testing more effective than Pap smear for detecting cervical cancer
- ID specialists ponder universal HCV screening
- Immuron receives patent claim for NASH treatment development
- Infant vaccination rates remain high despite racial, insurance disparities
- Influenza vaccination rates unchanged after ACIP withdraws LAIV recommendation
- Insurance disparities, tumor types drive lower colon cancer survival in blacks
- Intranasal tear neurostimulation increases acute tear production
- Lesions on MRI absent symptoms, history may yield false spondyloarthritis diagnosis
- Low skeletal muscle mass improves after successful HCV treatment
- Majority of women prefer annual screening mammograms, despite potential ‘harms’
- Many cancers associated with modifiable risk factors
- MRSA ventilator-associated pneumonia: Myth or reality?
- New single-dose RSV immunoprophylaxis safe, effective in preterm infants
- New York law improves HCV screening among baby boomers
- Oral insulin pill ineffective for delaying, preventing type 1 diabetes progression
- Pediatric Constipation Presents with Added Levels of Complex Care
- Physical activity linked to mood, anxiety levels
- Primary prevention improves colorectal cancer survival over early detection
- RNA blood test for diagnosing IBD, IBS launched
- Second Sight reports $6.7 million quarterly net loss
- Should people at low risk for HCV infection be screened for the virus?
- Study: Spectacle wearers liked wearing contacts while choosing glasses
- Tdap vaccinations in pregnant women jump more than 50%
- Teen alcohol, drug dependence linked to poor life outcomes in adulthood
- Thyroid cancer increases CVD morbidity risk
- Topical patidegib granted FDA breakthrough, orphan statuses for Gorlin syndrome
- VIDEO: Atacicept is a 'potential, exciting' treatment for lupus
- VIDEO: Percutaneous posterior stabilization of L1 to L5, percutaneous L3 biopsy in a spinal metastasis
- Working with clinical trials a common theme for KOL migration into industry
- Xen gel stent ‘transformative’ to glaucoma practice